|
|
|
|
|
Focus Groups |
New Scientists |
[Group Library]
(members only) |
|
 |
Mission Statement/Scope: |
The
New Scientists Focus Group encourages the development of scientists from the
multidisciplinary pharmaceutical arena through the provision of education,
dissemination of information and provision of opportunities to interact with
each other and eminent scientists.
|
|
|
|
About
the NSFG: |
The primary aim of the NSFG is to offer a forum for new scientists*, which
provides information and opportunities highly relevant to their current and
future needs. The focus group comprises members from a range of academia and
industry sectors working together to deliver its aims. The environment
created by the group at its events actively encourages interaction between
new scientists and eminent speakers. The group led the development of the
APS mentoring scheme. To date this has been achieved through a series of
seminars, workshops and articles, delivered over the last 13 years. The NSFG
is also actively involved in organising and chairing a speaker session at
the APS PharmSci Conference each year. Through its sessions at APS PharmSci
Conference, the group provides a unique opportunity to post-doctoral
researchers, lecturers and new scientists in the pharmaceutical arena to
communicate their research to the wider pharmaceutical world.
The NSFG also host Industrial Insights, a 2 day residential event which
gives undergraduate, postgraduate and post-doctoral pharmaceutical
scientists the opportunity to explore the numerous career paths open to them
within the pharmaceutical arena. These events have been held at the site of
a large Pharmaceutical company since 2008.
* the NSFG welcomes anyone who would like to be a member. However,
typically, a new scientist is an individual who is a student or up to 5
years into their scientific career.
|
|
|
Vision/Aims: |
The NSFG aims:
-
to demonstrate the
diversity of pharmaceutical sciences and highlight the many and varied
opportunities available to scientists from a wide-range of backgrounds and
disciplines;
-
to attract new
scientists to the APS by engaging and educating them about the aims and
benefits of the APS, and encourage them to become members of the APS;
-
to provide valuable
advice to new scientists on potential career paths and development
opportunities available to them within the pharmaceutical sphere;
-
to promote interaction
and collaboration between:
-
multidisciplinary
subjects which constitute the pharmaceutical sciences
-
new and eminent
scientists
-
industry, academia and
government;
-
to express the views of
new pharmaceutical scientists at national and international levels via the APS;
-
be the premier group
for these purposes within the UK;
-
be the premier vehicle
for the APS to attract new scientists into its membership.
These aims will be
achieved by:
-
organising and chairing
a session at the annual UK PharmSci conference which will showcase new
talent alongside newly appointed leaders in the academic and industrial
fields;
-
organising and hosting
a biennial conference at a major pharmaceutical site to showcase the
pharmaceutical arena, the opportunities available to new scientists within
the pharmaceutical sphere, and likely future directions using speakers
chosen from across a range of disciplines;
-
contributing to other
sessions and road-shows across the UK, supplementing other groups e.g. APS
focus groups BPSA, Young Chemical Engineers and publicising the work of
the NSFG and APS.
-
Facilitating the
Continuous Professional Development of all members of the APS
|
|
|
Committee Members: |
Helen Barker (Pfizer)
Claire Martin (University of Wolverhampton)
Mike Cram (Pfizer)
Matt Reason (GSK)
Spoorthi Dharmayat (Pfizer)
James Mann (Merck)
Sam Pygall (Merck)
|
Geoff Davison (BioNow)
Kieran Lennon (AstraZeneca)
Claire Thompson (Oxford
PharmaScience)
Rachel Bridson (University of Birmingham)
Carrie Truman (GSK)
Ashvin Patel (Kuecept)
|
  |
For more images of New
Scientsits events please click on the link below.
http://www.flickr.com/groups/newscientists |
|
|
|
|
|
|
|